VESALIUS-CV is the Latest Study in Amgen's PROFICIO Clinical Program Investigating the Impact of Repatha on CVD in Multiple Patient Populations

Cornerstone Healthcare Group ("Cornerstone"), a diversified healthcare company with operations in the specialty hospital, senior living, and behavioral health fields, announced two new partnerships, expanding its capabilities into home health and strengthening its operations in the long-term acute care space.

Applications Seek to Extend Use of BOTOX® for Patients 2 to 17 Years Old

Azmi Nasser, D.O., Medical Director at Arizona Pain Treatment Centers in Arizona, sends his best regards to the patients and team affected from the closure of Laser Spine Institute (LSI) in Scottsdale, Arizona. Each patient preparing for surgery with LSI and now in need of care will be welcomed. Laser spine surgery is offered by Dr. Nasser and his team is here to help.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801) today announced that the first patient has been dosed in ORIENT-32, a trial that evaluates Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody, in combination with IBI305, a recombinant humanized anti-vascular endothelial growth factor (anti-VEGF) monoclonal antibody, as first-line treatment for patients with advanced hepatocellular carcinoma (HCC).

New diagnostic criteria reduce hospital admissions and stress testing without increasing risk of heart damage

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial.

Clinical Study Shows That VR Intervention Improves Sleep, Quality of Life

Safety lead-in completed, no overlapping toxicities, combination is safe and well tolerated

SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, is pleased to announce the opening of its treatment center in Front Royal, Virginia.

Modernizing Medicine to Showcase Enhanced EMR including Tools to Improve Patient Engagement and Support Price Transparency and at HIMSS19

Clinical trial released after nearly 1,000 people participated

For men and women living with sexual dysfunction, the physicians at Tennessee Urology provide safe and effective new therapies designed to restore sexual function and quality of life.

CirrusMD, the market leader in chat-first virtual care delivery, today announced its new collaboration with Sanitas Medical Centers.

Innovative Technology Strengthens the Company's Comprehensive Knee Portfolio

Cleveland-based startup hires new CEO and prepares for market clearance

Phase 3 SPARTAN data served as basis for approval, which showed apalutamide decreased the risk of distant metastasis or death by 72 percent and improved median metastasis-free survival by more than two years

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

A Statement from the National Kidney Foundation (NKF)

New findings from an international research team led by psychiatrists at NYU School of Medicine show that a newly-developed analytic model can predict soon after a shocking or scary event – and with significant accuracy -- the likelihood of someone developing Post-Traumatic Stress Disorder (PTSD).